Comparative effects of ticrynafen and hydrochlorothiazide in the treatment of hypertension.

The New England Journal of Medicine
Veterans Administration Cooperative Study Group on Antihypertensive Agents

Abstract

Two dose levels of ticrynafen, a new uricosuric diuretic, and of hydrochlorothiazide were randomly assigned, double-blind to 240 men with initial diastolic blood pressures in the range of 95 to 114 mm Hg. A dose of 500 mg of ticrynafen once daily exerted an antihypertensive effect comparable to that of 50 or 100 mg of hydrochlorothiazide. Whereas serum uric acid levels rose in patients treated with hydrochlorothiazide, they fell markedly in those receiving ticrynafen. Otherwise, both diuretics produced similar chemical changes in serum. Patients tolerated ticrynafen as well as they did hydrochlorothiazide over a period of six months of observation, and there was no evidence of serious toxicity or loss of therapeutic effect with ticrynafen. This antihypertensive agent, in appropriate doses, appears to be as effective and well tolerated as hydrochlorothiazide, and in addition ticrynafen prevents hyperuricemia.

References

Jan 1, 1979·Nephron·R M StoteF Alexander
Jun 1, 1976·The American Journal of Medicine·O G Reese, T H Steele
Jan 1, 1966·Lancet·A Breckenridge
Sep 1, 1966·The New England Journal of Medicine·P J CannonJ H Laragh

❮ Previous
Next ❯

Citations

Sep 6, 1979·The New England Journal of Medicine·T H Steele
Nov 1, 1979·The New England Journal of Medicine·A Leonard
Nov 22, 1979·The New England Journal of Medicine·W M BennettR Hutchings
Dec 20, 1979·The New England Journal of Medicine·E D Frohlich
Nov 24, 1983·The New England Journal of Medicine·P W LavoriM Polansky
Dec 5, 1985·The New England Journal of Medicine·K Godfrey
May 21, 2004·QJM : Monthly Journal of the Association of Physicians·M R DavidsM L Halperin
Jan 14, 2012·BMJ : British Medical Journal·Hyon K ChoiLuis A García Rodríguez
Apr 1, 1981·Clinical Toxicology·D PowersK Mirahmadi
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·N K Hollenberg, G H Williams
Nov 1, 1980·Kidney International·B T Emmerson
Jun 1, 1986·Hypertension·P F Magee, E D Freis
Sep 1, 1980·Clinical and Experimental Pharmacology & Physiology·R G WalkerP Kincaid-Smith
May 17, 1980·British Medical Journal·R G WalkerP Kincaid-Smith
May 27, 2016·Journal of Pediatric Endocrinology & Metabolism : JPEM·Maria GüemesKhalid Hussain
Mar 5, 2016·International Journal of Cancer. Journal International Du Cancer·Tianyi HuangShelley S Tworoger
Mar 12, 2020·Journal of General Internal Medicine·Jill J HallJohn-Michael Gamble
Oct 1, 1980·British Journal of Clinical Pharmacology·J B MyersT O Morgan
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·P Lund-Johansen
May 13, 2011·The New England Journal of Medicine·Franz H MesserliDan Halpern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
O G Reese, T H Steele
The New England Journal of Medicine
R S King, B A Wichman
Clinical and Experimental Hypertension. Part A, Theory and Practice
P L MaliniE Ambrosioni
© 2021 Meta ULC. All rights reserved